Status:
COMPLETED
Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
RATIONALE: Finding genetic markers for thyroid cancer in a biopsy specimen may help doctors diagnose thyroid cancer. PURPOSE: This clinical trial is studying how well genetic analysis works in diagno...
Detailed Description
OBJECTIVES: * Evaluate the diagnostic accuracy of biomarkers and mRNA expression analysis using fine-needle aspiration (FNA) biopsy samples from patients with thyroid nodules. * Correlate the level o...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Diagnosis of a thyroid nodule that requires fine-needle aspiration biopsy or thyroidectomy to exclude a diagnosis of thyroid cancer
- PATIENT CHARACTERISTICS:
- Platelet count ≥ 70,000/mm\^3
- PT (INR) ≤ 14.5
- PTT ≤ 35.2
- Not pregnant
- PRIOR CONCURRENT THERAPY:
- No aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) 7 days before sample procurement
Exclusion
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT00316823
Start Date
July 1 2005
Last Update
February 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States, 94115